Objective-Therapeutic angiogenesis with cell transplantation represents a novel strategy for severe ischemic diseases.
P eripheral artery disease (PAD) is characterized by a reduced blood supply due to narrowed or blocked arteries. Therapeutic angiogenesis is a novel strategy to treat no-option patients with severe PAD by promoting the formation of collateral vessels and angiogenesis. We previously reported therapeutic angiogenesis using autologous bone marrow mononuclear cell transplantation (TACT trial) into the ischemic tissues in patients with severe PAD. [1] [2] [3] Although the safety and efficiency of the TACT have been confirmed, a certain portion of patients showed poor response to the TACT procedure. 3 In general, patients with severe PAD and multiple coronary risk factors had reduced responses to any angiogenic cell therapies. 4 -7 The most common and widely used method of cell transplantation is direct injections of cell suspensions using injection needles. However, this simple method has several disadvantages such as rapid cell loss caused by a leakage of injected fluid, late cell loss due to unstable cell homing, and needle-mediated direct tissue damages. 8 -10 Thus, alternative cell source and/or cell application strategy have been explored.
Recent studies showed that mesenchymal stem cells (MSCs) have an ability to regenerate damaged tissues. Bone marrow-derived MSCs, for example, are multipotent cells that can differentiate into osteoblasts, chondrocytes, adipocytes, and smooth muscle cells. [11] [12] [13] MSC implantation also induced angiogenesis by releasing various angiogenic growth factors including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and stromal cell-derived factor-1␣. 14, 15 Regarding cell application methods, several tissue engineering (TE) technologies are emerging for regenerative medicine. Ito and colleagues reported a novel TE strategy, termed magnetic force-based TE (Mag-TE). 16 In this Mag-TE system, magnetite Fe 3 O 4 nanoparticles with 10 nm in diameter were first taken up by liposomes, creating magnetic cationic liposomes (MCLs) with a positive surface charge. Since the cell membrane is negatively charged, MCLs can easily contact target cells electrostatically, and target cells can be magnetized by fusion with MCLs. Magnetized target cells were then cultured, and cell sheets could be created using external magnetic force. This Mag-TE technology prompted us to construct a variety of cell sheets such as cardiomyocytes, keratinocytes, or hepatocytes. 16 -18 In the present study, we attempted to construct multilayered 3-D human MSC sheets using the Mag-TE system, and we tested therapeutic impacts of the MSC sheets on ischemia-induced angiogenesis in vivo.
Materials and Methods
Methods in detail are described in the online data supplement files, available at http://atvb.ahajournals.org.
Construction of Human MSC Sheets
MSC sheets were constructed using the Mag-TE system. To magnetically label the cells, human MSCs were first incubated with MCLs at a concentration of 100 pg-magnetite/cell. After 4 hours incubation, MSCs (2ϫ10 6 cells) labeled with MCLs were seeded into a 24-well ultralow-attachment cell culture plate (Corning, NY). Then a cylindrical neodymium magnet (4000 Gauss) was placed on the reverse side of the culture plate to give a vertical magnetic force to the plate, and the cells were cultured for an additional 24 hours. After the culture, the neodymium magnet at the reverse side of the culture plate was removed. A hydrophilic polyvinylidene difluoride membrane was covered on top of an Alnico magnet, and the magnet was positioned at the surface of culture medium so that the MSC sheets were attached by the magnetic force and stuck onto the polyvinylidene difluoride membrane-covered magnet surface. 16 
Mouse Model of Hind Limb Ischemia
Male nude mice (BALB/c nu/nu) at 10 to 12 weeks old were obtained from the SLC Co Ltd (Nagoya, Japan), cared and used in accordance with the guidelines issued by the National Institutes of Health. These mice were subjected to unilateral hind limb ischemia surgery under anesthesia with sodium pentobarbital (30 mg/kg intraperitoneally) as described previously. 19 Mice were randomly divided into 3 groups. The control group (nϭ9) received phosphate-buffered saline. The MSC-injected group (nϭ9) received MSCs magnetically labeled with MCLs (2ϫ10 6 cells/200 L in phosphate-buffered saline; nϭ9) that were directly transplanted into 6 sites in the ischemic limb by a needle injection. The MSC-sheet group (nϭ9) received the Mag-TE constructed MSC sheet (2ϫ10 6 cells/sheet) placed on top of the ischemic adductor muscles using an Alnico magnet. After placement of the sheet, the skin was closed with a simple interrupted 5 to 0 suture. In additional experiments, MSCs labeled or unlabeled with MCLs (2ϫ10 6 cells/ 200 L in phosphate-buffered saline; nϭ9 each group) were transplanted into 6 sites in the ischemic limb by needle injections to examine the effects of MCL labeling itself on angiogenesis. We choose to implant MSCs on the ischemic adductor muscles, because adductor muscles are exposed to most severe ischemia after surgery in this model. 20
Results

Characteristics of MSCs Labeled With MCLs
We first assessed the characteristics of MSCs magnetically labeled with MCLs by flow cytometry. There was no significant differences in cell size, as assessed by forward scatter (FSC) between MSCs labeled with MCLs and unlabeled MSCs, whereas cytosolic structure as assessed by sideward scatter was apparently changed by the incorporation of magnetic particles within the MSCs (Supplemental Figure  IA) . We also compared the cell surface markers between MSCs labeled with MCLs and unlabeled MSCs. Cells in both groups expressed CD44 and CD 166, but not CD45 (Supplemental Figure IB ). To determine sarcomeric F-actin organization, MSCs labeled or unlabeled with MCLs were stained with fluorochrome-conjugated phalloidin. As shown in Supplemental Figure IC , the incorporation of magnetic particles within the MSCs had no effect on actin organization and cell surface area.
We next examined the expression of the angiogenic cytokines using Proteome Profiler array. In MSCs labeled with MCLs and unlabeled MSCs, a variety of angiogenic factors such as acidic fibroblast growth factor, basic fibroblast growth factor, and VEGF were highly expressed. These expressions did not differ between the two groups (Supplemental Figure ID) . Thus, the incorporation of magnetic particles within the cells did not change their phenotype and functionality. Figure 1A shows a macroscopic human MSC sheet constructed on an ultralow-attachment culture plate using the Mag-TE system. The Mag-TE system caused free MSCs to form a sheet-like structure by cell pileup according to the magnetic force after 24 hours incubation ( Figure 1B ). The MSC sheets had a brown color that was the color of magnetite Fe 3 O 4 nanoparticles. Hematoxylin and eosin staining showed that the MSC sheet comprised 10 to 15 layered MSCs with approximately 300 m in thickness ( Figure 1B ). Immunofluorescent staining confirmed the expression of gap junction protein connexin 43 within the MSC sheet ( Figure 1C ).
Construction of Human MSC Sheets by the Mag-TE and Application to Nude Mice
To further investigate the cellular condition in the human MSC sheet, proliferating cell nuclear antigen and TUNEL stainings were performed. About 40% of MSCs within the sheet were proliferating cell nuclear antigen-positive, and thus these cells were proliferating ( Figure 1D ). TUNELpositive-apoptotic cells were virtually not observed at 24 hours after the initiation of the sheet construction ( Figure 1E ). There were no significant differences in the proportion of TUNEL-positive-apoptotic cells among the upper layer (1.01Ϯ0.36%), middle layer (1.18Ϯ0.52%), and lower layer (0.99Ϯ0.54%) of the MSC sheets. Figure 2A to 2C show serial procedures for harvesting a MSC sheet constructed by the Mag-TE system. A neodymium magnet under the culture plate was removed. Then, an Alnico magnet covered with a hydrophilic polyvinylidene difluoride film was positioned at the surface of culture medium (Figure 2A ). A MSC sheet was recovered by magnetic force, and it was then placed onto the adductor muscles of mouse hind limb using an Alnico magnet ( Figure  2B and C).
In the MSC-injected group, cell suspensions were transplanted by needle injections. These cells were engrafted into the muscles with a limited area, and some cells were still present at 3 weeks after the transplantation ( Figure 2D and E). In the MSC-sheet group, a cell sheet was successfully engrafted, and new blood vessels were formed within the sheets in the MSC sheet group ( Figure 2F and G). Furthermore, to identify the transplanted cells in ischemic tissue, we assessed the human lamin mRNA levels, which are nuclear membrane structural component, in ischemic tissue at day 7 after transplantation using real-time PCR. The mRNA levels of human lamin were significantly higher in MSC sheet group than MSC-injection group ( Figure 2H ).
Augmentation of Ischemia-Induced Revascularization by the MSC Sheet Transplantation
We next examined whether transplantation of MSC sheet could augment ischemia-induced angiogenesis using a mouse model of hind limb ischemia. Figure 3A shows representative laser Doppler blood flow images of hind limb blood flow immediately after the ischemia surgery and at different time points thereafter. Quantitative analysis revealed that the MSC-injected group showed a significant increase in limb blood perfusion at days 7, 10, 14, and 21 after surgery compared to the control group ( Figure 3B ). Moreover, a greater degree of blood perfusion was observed in the ischemic limb of the MSC-sheet group compared to the MSC-injected group ( Figure 3B ).
To further investigate the extent of angiogenesis at the microcirculation level, capillary density and arteriole density were also measured in histological sections harvested from the ischemic adductor and gastrocnemius muscles. Figure 3C shows a quantitative analysis revealing that, on postoperative day 21, the tissue capillary and arteriolar densities in ischemic muscles were significantly increased in the MSC-injected group and the MSC-sheet group compared to the control group. The capillary and arteriolar densities tended to be greater in the MSC-sheet group compared to the MSC-injected group ( Figure 3C) . 
MSC Sheet Transplantation Increased the VEGF Expression
We investigated whether transplantation of MSC sheet stimulated the expression of VEGF in the ischemic hind limb tissues. At postoperative day 7, mouse VEGF mRNA levels increased in the MSC-injected group and the MSC-sheet group compared to the control group. Expression of mouse VEGF mRNA was also greater in the MSC-sheet group than in the MSC-injected group (Supplemental Figure IIA) . Human VEGF originating from transplanted cells was investigated (Supplemental Figure IIB) . Human VEGF mRNA level was increased significantly in the MSC-injected group and MSC-sheet group compared to the control group at day 3 and day 7. The expression of human VEGF mRNA was greater in the MSC-sheet group than in the MSC-injected group at day 3 (Supplemental Figure IIB) . Furthermore, to confirm whether implanted MSC-sheet secrete VEGF protein in the ischemic tissues, frozen sections from ischemic tissues of mice were stained with VEGF monoclonal antibodies. VEGF was detected in the cytoplasm of skeletal myofibers in the ischemic muscles, and this expression level was higher in the MSC-sheet group than in the MSC-injected group consistent with the mRNA levels (Supplemental Figure IIC) . Transplantation of MSCs did not affect plasma VEGF protein levels (Supplemental Figure IID) .
Transplantation of MSC Sheets Inhibited Skeletal Muscle Cell Apoptosis in Ischemic Tissues
To evaluate the cell viability after the MSC sheet transplantation, we performed TUNEL staining in the ischemic tissues. Representative photographs of TUNEL-positive nuclei in the ischemic muscles are shown in Supplemental Figure IIIA . Quantitative analysis revealed a significantly lower proportion of TUNEL-positive apoptotic cells in the ischemic muscles of the MSC-sheet group compared to the control and MSC-injected groups after hind limb surgery (Supplemental Figure IIIB) . Recently, it was reported that magnetic force itself elicits an intrinsic antioxidative peroxidase-like activity. 21 We, thus, examined whether MCLs could reverse the oxidation reaction of DAB mediated by H 2 O 2 (Supplemental Figure IIIC) . To test the effects of MCLs on peroxidase-like activity and cell viability, MSCs labeled or unlabeled with MCLs were subjected to glutathione-depleting agent L-buthionine-[S,R]sulfoximine (BSO) for 48 hours in vitro. Glutathione -depletion by BSO led to an increase in the ratio of trypan blue-positive-dead cells in MSCs. In MSCs labeled with MCLs, however, BSO-induced cell deaths were markedly attenuated (Supplemental Figure IIID) . Treatment with BSO increased the expression of proapoptotic protein Bax by 1.6-fold, and this effect was also attenuated by the MCL labeling (Supplemental Figure IIIE) . Thus, the MCL labeling itself likely to contributes to the cell survival action after MSC sheets transplantation via their peroxidase-like antioxidative activity. We also analyzed the effect of the MCL labeling itself on blood flow recovery of ischemic muscles in WT mice on postoperative day 0, 3, 7, 14, and 21. The MSCs labeled with MCLs-injected group showed a significant increase in limb flow at 7, 14, and 21 days after hind limb surgery compared with the MSCs unlabeled with MCLsinjected group and the control group (Supplemental Figure  IIIF ). Supplemental Figure IIIF shows a quantitative analysis revealing that, on postoperative day 21, the tissue capillary and arteriolar densities in ischemic muscles were significantly increased in the MSCs labeled with MCLs-injected group and the MSCs unlabeled with MCLs-injected group compared to the control group. The capillary density, but not arteriolar density, was significantly greater in the MSCs labeled with MCL-injected group compared to the MSCs unlabeled with MCL-injected group (Supplemental Figure IIIG) .
Localization of Transplanted MSC Sheets at Chronic Phase
We examined whether in vivo implanted MSC sheet could differentiate into endothelial cells at chronic phase. At 6 weeks after transplantation, a large number of newly formed capillary and mature blood vessels invaded into the MSC sheet (Supplemental Figure IVA) . Immunofluorescence staining revealed that implanted MSC sheet expressed anti-mouse ␣-SMA-positive cells and anti-mouse CD31-positive cells (Supplemental Figure IVA) . However, anti-human CD31 and anti-human ␣-SMA-positive cells were not detected (Supplemental Figure IVB) . These results indicate that implanted MSC-sheet component did not directly differentiate into vascular endothelial cells.
Discussion
In the present study, we have used a new modality for TE, termed Mag-TE system, and successfully created human MSC sheet comprising 10 to 15 layered cells with approximately 300 m in thickness. The Mag-TE system enabled us to recover the MSC sheet en block with an Alnico magnet, and we could transplant it to the mouse hind limb ischemia model under conditions that well preserved cell-to-cell connection. The transplanted MSC sheet was successfully engrafted into the ischemic tissues, stimulated revascularization, and inhibited host skeletal muscle cell apoptosis in response to limb ischemia. Thus, our new methodology, the Mag-TE system, would provide a novel modality in the field of regenerative medicine using cell sheets.
A number of clinical trials have supported the safety and efficacy of therapeutic angiogenesis by cell transplantation for patients with severe PAD and myocardial infarction. 22, 23 In various animal models and clinical trials, the conventional methods for cell transplantation were direct injection of free cell suspensions with syringe needles. However, this method has several disadvantages, such as cell loss caused by leakage of injected cell suspension, lower cellular forming rate, and tissue damages. 8 -10 Studies reported that cells administered by a direct syringe injection were lost for a short period and only 3% to 5% cells survived at day 7. 9,10 Interestingly, apoptosis within the MSC sheets was not observed at 24 hours of sheet construction. About 40% proliferating cell nuclear antigen-positive-proliferative cells were also confirmed within the MSC sheets. Thus, constructed MSC sheet by the Mag-TE system is highly viable and proliferative for therapeutic use. In addition, transplantation of MSC sheets significantly reduced proportion of TUNEL-positive apoptotic cells in the host ischemic muscles.
Gao and colleagues previously showed that Fe 3 O 4 nanoparticles themselves have an intrinsic peroxidase-like activity. 21 In the present study, we confirmed that the MCLs elicited peroxidase-like activity when MCLs were coincubated with human MSCs. In cultured MSCs, MCL labeling inhibited the BSO-mediated cell death and the expression of proapoptotic protein Bax. It is then conceivable that MCL labeling suppressed reactive oxygen species production via the peroxidase-like activity, which might result in the inhibition of host cell apoptosis. Taken together, the Mag-TEcreated human MSC sheet would improve MSC viability, host cell viability and thereby potentially improve cell therapy for ischemic diseases.
One of the major mechanisms of cell therapy is mediation of angiogenesis by releasing multiple angiogenic cytokines such as VEGF rather than by a direct differentiation of transplanted cells into mature endothelial cells. Miyahara and colleagues reported that transplantation of monolayer MSCs acted through a paracrine fashion to trigger angiogenesis in a rat myocardial infarction model. 23 We confirmed that VEGF mRNA expression in the ischemic tissues was significantly increased in the MSC-sheet group compared to the MSCinjected group. Therefore, angiogenic cytokines such as VEGF might be secreted stably and continuously from the implanted MSC sheet in ischemic tissues. It is conceivable that transplantation of MSC sheet promotes angiogenesis more effectively compared to conventional MSC cell suspension injection method.
Some groups have created cell sheet-based tissue engineering, which use 2D cell sheets harvested from temperaturesensitive culture surfaces and created 3D tissues by layering cell sheets without scaffolds. 24 -27 However, it has been shown that the sheet comprising 4 or more layers causes the central necrosis due to lack of oxygen supply. In addition, to fabricate the multilayered sheets, they extend the culture by 1 week. In the present study, we could create the MSC sheet comprised 10 to 15 layered MSCs with approximately 300 m in thickness. We also fabricated the multilayered sheets for only 24 hours. Thus, constructed MSC sheet by our system is highly viable, proliferative, and convenient in means.
The present study has several limitations. First, we did not assess whether MSC sheet created by the magnetic nanoparticle-based tissue engineering technology elicited a foreign body reaction or not. Nude mice (BALB/c nu/nu) were used for this study to avoid immunologic rejection of the transplanted MSCs. Second, the surgical layering of MSC-sheets labeled with MCL on a muscle surface is fundamentally different from a simple MSC injection. There might be obvious hindering factors associated with placing cells on top of target tissue such as the requirement for surgery with collateral damage. Third, the link between VEGF and apoptosis after MSC sheet transplantation has not been clarified. It has been reported that VEGF induces cell survival in various cell types including endothelial cells, whereas the MCL labeling itself contributed to the cell survival via their peroxidase-like antioxidative activity in the present study. Thus, MSC-sheet might exert both direct and indirect antiapoptotic actions on the ischemic tissue. Future experimental studies will be required to elucidate the link between VEGF and apoptosis in the ischemic tissue after MSC sheet transplantation. Finally, we did not assess the dose-response relationship for MSCs in our ischemic animal model.
In conclusion, our human MSC sheet constructed by a novel magnetic force-based TE technology (i.e., Mag-TE system) was successfully engrafted into the ischemic tissues of nude mice and promoted revascularization. Transplantation of MSC sheet may become a novel therapeutic modality for regenerative medicine in ischemic limb as well as cardiac diseases.
